Rational design of Harakiri (HRK)-derived constrained peptides as BCL-xL inhibitors. (2023)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/d2cc06029a

PubMed Identifier: 36692261

Publication URI: http://europepmc.org/abstract/MED/36692261

Type: Journal Article/Review

Volume: 59

Parent Publication: Chemical communications (Cambridge, England)

Issue: 12

ISSN: 1359-7345